Explore Business Standard
The consortium will offer Novartis India's public shareholders ₹860.64 per share, an exchange filing showed, representing a 3.6 per cent premium to its closing price on Thursday
 "Novartis to sell majority stake in India unit in ₹1,446 crore deal")
Swiss drugmaker Novartis said on Friday it would sell its entire 70.68 per cent stake in its listed Indian unit for ₹1,446 crore ($159 million).
The stake will be acquired by a consortium of WaveRise Investments, ChrysCapital and Two Infinity Partners.
The companies have also made an offer to purchase an additional 26 per cent stake from Novartis India's public shareholders, under takeover regulations that mandate such an exercise on purchase of a shareholding of over 25 per cent.
The consortium will offer Novartis India's public shareholders ₹860.64 per share, an exchange filing showed, representing a 3.6 per cent premium to its closing price on Thursday.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
First Published: Feb 20 2026 | 9:37 AM IST
